CNR1 and cardiomyopathy: CB1 blockade is a proposed druggable target in cardiomyopathies because inhibition reverses negative inotropy.[4] We hypothesize that the high CBD content in the patient's cannabis oil, in conjunction with his standard cardiac care, to be responsible for his improved functional capacity.